Showing 1 posts of 1 posts found.


Emergent snaps up Adapt and its opioid overdose therapy for $735m

August 29, 2018
Research and Development, Sales and Marketing Emergent, Narcan, naloxone, opioid crisis, opioids, pharma

Emergent BioSolutions has announced it has signed an agreement to acquire Adapt Pharma at a valuation of $735 million, a …

Latest content